CMS Open Payments · Program Year 2024
Blue Sky Bio, LLC
Blue Sky Bio, LLC reported $8,658,422.00 across General Payments, Research, and Ownership to 48 physicians and teaching hospitals across 50 transactions.
- $8.7M
- All-tracks total
- 50
- Transactions
- 48
- Recipients
- +$31.8K
- General Payments vs PY2023
Blue Sky Bio, LLC reported $8,658,422.00 across all CMS Open Payments tracks (General + Research + Ownership) to 48 physicians and teaching hospitals in Program Year 2024 - ranking #193 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $314,197.00, averaging $180.4K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer blue-sky-bio-llc Blue Sky Bio, LLC
$8.7M · #193/1,925 · 0.1% industry · PY2024
- TOT $8.7M
- RANK #193
- SHARE 0.1%
- TXN 50
- RCP 48
- CAT 1
- GEN $314.2K
- ΔGEN +$31.8K
- TOP1 38.2%
- PY 2024
Volume peers
Nearest volume peer: Contego Medical, Inc ($8.7M)
Blue Sky Bio, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Blue Sky Bio, LLC's CMS-reported General Payments increased by $31.8K (+11.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: BLUE SKY BIO, LLCPY2023: BLUE SKY BIO, LLCPY2024: Blue Sky Bio, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $282,400.00
- PY2024
- $314,197.00
What the Data Shows for Blue Sky Bio, LLC
Rank #193 of 1,925 companies in CMS Open Payments for 2024 belongs to Blue Sky Bio, LLC, which reported $8,658,422.00 across 50 transactions to 48 recipients - a comparatively small 0.1% slice of all industry payments reported nationwide for the year. Averages work out to $173.2K per transaction and $180.4K per recipient.
"Consulting Fee" leads the 1-category general-payment breakdown below at $314.2K (100.0% of General Payments, 48 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 1 types of general payments, Blue Sky Bio, LLC's largest category was "Consulting Fee" at $314.2K - 100.0% of General Payments.
How Blue Sky Bio, LLC divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $314.2K | 48 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $314,197.00 (100.0%) of $314,197.00 in this company's General Payments records across 4 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Blue Sky Bio, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Nathan Cory Glenn
$120,000.00 across 12 reported transactions
- 2
Baron Grutter
$74,197.00 across 12 reported transactions
- 3
Robert Mikhli
$60,000.00 across 12 reported transactions
- 4
Marc Lipkin
$60,000.00 across 12 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Blue Sky Bio, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Blue Sky Bio, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Blue Sky Bio, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Si-Technology, LLC
Ignite Orthopedics, LLC
SpectraWAVE, Inc
Indivior Inc.
Shoulder Innovations, Inc.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.